Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.

Dua AB, Spiera RF, Dikranian A, Calabrese C, Bingham CO, Ford K, Fiore S, Araujo L, Petruski-Ivleva N, Isaman DL, Xie F, Curtis JR.

Open source

DOI: 10.1136/rmdopen-2026-006850
Published: 2026-08-03
Container: RMD Open
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2026-006850,
  title = {Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.},
  author = {Dua AB and  Spiera RF and  Dikranian A and  Calabrese C and  Bingham CO and  Ford K and  Fiore S and  Araujo L and  Petruski-Ivleva N and  Isaman DL and  Xie F and  Curtis JR.},
  year = {2026},
  journal = {RMD Open},
  doi = {10.1136/rmdopen-2026-006850},
  url = {https://doi.org/10.1136/rmdopen-2026-006850}
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.
AU  - Dua AB
AU  -  Spiera RF
AU  -  Dikranian A
AU  -  Calabrese C
AU  -  Bingham CO
AU  -  Ford K
AU  -  Fiore S
AU  -  Araujo L
AU  -  Petruski-Ivleva N
AU  -  Isaman DL
AU  -  Xie F
AU  -  Curtis JR.
PY  - 2026
JO  - RMD Open
DO  - 10.1136/rmdopen-2026-006850
UR  - https://doi.org/10.1136/rmdopen-2026-006850
ER  -

APA

AB, D., RF, S., A, D., C, C., CO, B., K, F., S, F., L, A., N, P., DL, I., F, X., & JR., C. (2026). Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.. RMD Open. https://doi.org/10.1136/rmdopen-2026-006850

Source records

europe-pmc · retrieved 2026-09-27T02:17:35.715Z
doaj · retrieved 2026-09-27T02:17:35.707Z